Source: iQoncept / Shutterstock
Cue Biopharma (NASDAQ:CUE) just reported results for the first quarter of 2024.
- Cue Biopharma reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -28 cents.
- The company reported revenue of $1.72 million.
- This was 41.90% better than the analyst estimate for revenue of $1.21 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/cue-stock-earnings-cue-biopharma-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC